Correlation Between Genmab AS and Wirtek AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genmab AS and Wirtek AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genmab AS and Wirtek AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genmab AS and Wirtek AS, you can compare the effects of market volatilities on Genmab AS and Wirtek AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genmab AS with a short position of Wirtek AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genmab AS and Wirtek AS.

Diversification Opportunities for Genmab AS and Wirtek AS

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Genmab and Wirtek is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Genmab AS and Wirtek AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wirtek AS and Genmab AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genmab AS are associated (or correlated) with Wirtek AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wirtek AS has no effect on the direction of Genmab AS i.e., Genmab AS and Wirtek AS go up and down completely randomly.

Pair Corralation between Genmab AS and Wirtek AS

Assuming the 90 days trading horizon Genmab AS is expected to generate 0.98 times more return on investment than Wirtek AS. However, Genmab AS is 1.02 times less risky than Wirtek AS. It trades about 0.08 of its potential returns per unit of risk. Wirtek AS is currently generating about -0.48 per unit of risk. If you would invest  144,600  in Genmab AS on September 20, 2024 and sell it today you would earn a total of  4,050  from holding Genmab AS or generate 2.8% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Genmab AS  vs.  Wirtek AS

 Performance 
       Timeline  
Genmab AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genmab AS has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Wirtek AS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Wirtek AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Genmab AS and Wirtek AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genmab AS and Wirtek AS

The main advantage of trading using opposite Genmab AS and Wirtek AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genmab AS position performs unexpectedly, Wirtek AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wirtek AS will offset losses from the drop in Wirtek AS's long position.
The idea behind Genmab AS and Wirtek AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm